NEO
NeoGenomics Laboratories, Inc.
·
$14.61
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Terminal终端 ↗
NeoGenomics Laboratories, Inc. · Health Care
NEO
$14.61
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing.NeoGenomicsLaboratories,Inc.，亦称NeoGenomics或Neo，是一家美国CLIA认证的临床实验室、制药服务和信息服务公司，专门从事癌症遗传学诊断检测。
Speculative / unprofitable投机／未盈利
Small cap小盘
$2B
Engine stance引擎立场2026-07-20
Extended — don't chase; wait for a pullback过度拉升 — 勿追高；等待回撤
Stretched/late — protect gains and don't start new positions; let the next low set up first.已拉伸／晚期——保护利润，不要新开仓；先等下一个低点构筑成形。
Key Statistics关键统计
Price价格
$14.61
3.6% below 52-week high低于52周高点 3.6%
Market Cap市值
$2B
Normal volume正常成交量
Beta贝塔
1.17
Moves about 1.2x the market波动幅度约为市场的 1.2 倍
RSI (14)RSI（14）
65
Elevated偏高
Next Earnings下次财报
2026-08-04 (16d)
Volatility Rank波动率分位
70th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
9.0% of float
Performance价格表现
| Period周期 | NEO | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | +3.5% | -1.5% | Beat the index by 5.0 points跑赢指数 5.0 个百分点 |
| 1 Month近1月 | +40.8% | +0.6% | Beat the index by 40.2 points跑赢指数 40.2 个百分点 |
| 3 Months近3月 | +75.0% | +4.7% | Beat the index by 70.3 points跑赢指数 70.3 个百分点 |
| 6 Months近6月 | +14.2% | +7.8% | Beat the index by 6.4 points跑赢指数 6.4 个百分点 |
| Year to date年初至今 | +24.2% | +9.1% | Beat the index by 15.1 points跑赢指数 15.1 个百分点 |
| 1 Year近1年 | +117.4% | +19.4% | Beat the index by 98.0 points跑赢指数 98.0 个百分点 |
| 3 Years近3年 | -14.9% | +69.4% | Lagged the index by 84.3 points落后指数 84.3 个百分点 |
Technicals技术面
RSI (14)RSI（14）
65
Elevated偏高
vs 50-day相对50日均线
+27.6% vs 50-day avg
vs 200-day相对200日均线
+38.3% vs 200-day avg
Volatility rank波动率分位
70th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Buy zone买入区间
$14.21
Don't chase above不追高于
$14.61
Stop止损
$10.38
Extended — wait for a pullback过度拉伸 — 等待回撤
Earnings财务业绩
16
days until next report天后公布财报
2026-08-04
Estimates being raised — 6 analysts预期上调 — 6 位分析师
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | NEO | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/B市净率 | 2.25x | 3.52 | 70% |
| Earnings yield盈利收益率 | -5.73% | 2.72 | 14% |
| FCF yield自由现金流收益率 | -1.16% | 3.94 | 11% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 10.4%
Free Cash Flow自由现金流
Margins利润率
-12.9%Return on Equity股本回报率
-7.9%Return on Assets资产回报率
Leverage杠杆
| Current ratio流动比率 | 4.26 |
Capital Allocation资本配置
| Stock-based comp股权薪酬 | $41.3M |
| Share count change (1y)股数变化（1年） | +0.7% |
Piotroski皮奥特罗斯基 4/9
Altman Z阿尔特曼Z: grey (2.2)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Roughly fair vs sector相对行业估值合理
Cheaper than 40% of its sector on blended multiples综合估值倍数低于行业内 40% 的公司
Beta市场敏感度
1.17×
0.21×3×
Moves about 1.2× the market波动幅度约为市场的 1.2 倍
Financial Health财务健康
4/9
Altman阿尔特曼: grey
Weak financial health财务健康状况偏弱
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Short interest changed +37.5%空头仓位变动 +37.5%
Technical技术面
NEO took relative-strength leadershipNEO 取得相对强弱领先
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$0.6M net (0 buyers, 2 sellers)-$0.6M 净值（0 买家，2 卖家）
Signal History信号历史
TOP WATCH
NEARING A HIGH
Jul 13, 2026
NEO took relative-strength leadershipNEO 取得相对强弱领先
Relative strength vs SPY crossed above the 90th percentile of the last 90 days — leadership tends to persist. $14.11.相对标普500的强弱上穿近90日的第90百分位 — 领先往往延续。$14.11。
Jul 10, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 10, 2026
NEO daily MACD crossed downNEO 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $14.11.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$14.11。
Jul 9, 2026
BOTTOMING → NEARING A HIGH筑底中 → 接近高点
TAKE PROFITS止盈
Jul 9, 2026
NEO RSI reached overboughtNEO RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $14.73.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$14.73。
Jul 8, 2026
NEARING A HIGH → BOTTOMING接近高点 → 筑底中
BUY SETUP买入预备
Jul 2, 2026
Golden cross on NEONEO 金叉
The 50-day average crossed above the 200-day — a slow, widely-watched bullish trend signal. $15.16.50日均线上穿200日均线 — 一个滞后但广受关注的看多趋势信号。$15.16。
Jun 25, 2026
NEO made a new 52-week highNEO 创52周新高
Price reached a fresh 52-week high — a momentum / trend extreme the whole market watches. $13.73.价格创出52周新高 — 全市场关注的动量/趋势极值。$13.73。
Jun 24, 2026
UPTREND → NEARING A HIGH上涨趋势 → 接近高点
TAKE PROFITS止盈
Jun 24, 2026
NEO daily MACD crossed upNEO 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $12.90.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$12.90。
Jun 24, 2026
NEO RSI reached overboughtNEO RSI进入超买
RSI(14) crossed above 70 — stretched to the upside; context, not a timing trigger alone. $12.90.RSI(14)上穿70 — 上行过度；仅作背景，单独不构成择时。$12.90。
Showing last 15 of显示最近15条，共 264 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.20
Value价值
-0.7
Profitability盈利能力
-0.5
Quality质量
+0.2
Investment资本投入
+1.5
Low volatility低波动
-1.5
Low market beta低市场敏感度
-0.4
Earnings quality盈利质量
+0.5
Short interest空头兴趣
+0.3
Company Profile公司档案
NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing.NeoGenomicsLaboratories,Inc.，亦称NeoGenomics或Neo，是一家美国CLIA认证的临床实验室、制药服务和信息服务公司，专门从事癌症遗传学诊断检测。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Margin compression despite revenue growth
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。